|
2011
Vigneron S., Gharbi-Ayachi A., Raymond A.A., Burgess A., Labbé J.C.,
Labesse G., Monsarrat B., Lorca T., Castro A. (2011).
Characterization of the Mechanisms Controlling Greatwall Activity.
Mol Cell Biol. 2011 Jun;31(11):2262-75.
Villeneuve C.,
Baricault L., Canelle L., Barboule N., Racca C., Monsarrat B., Magnaldo
T., Larminat F. (2011).
Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2
binding protein in human cells. Mol Biol Cell. 2011
Apr;22(7):999-1013.
Hsu C.Y., Henry J., Raymond A.A., Méchin M.C.,
Pendaries V., Nassar D., Hansmann B., Balica S., Burlet-Schiltz O.,
Schmitt A.M., Takahara H., Paul C., Serre G., Simon M. (2011). Deimination of
human filaggrin-2 promotes its proteolysis by calpain 1. J Biol
Chem. 2011 Jul 1;286(26):23222-33.
Aressy B., Jullien D., Cazales M., Marcellin M., Bugler B.,
Burlet-Schiltz O., Ducommun B. (2011). A screen for
deubiquitinating enzymes involved in the G2/M checkpoint identifies
USP50 as a regulator of HSP90-dependent Wee1 stability. Cell Cycle. 2010 Sep 15;9(18):3815-22.
Lobjois V.,
Froment C., Braud E., Grimal F., Burlet-Schiltz O., Ducommun B., Bouche
J.P. (2011). Study of
the docking-dependent PLK1 phosphorylation of the CDC25B
phosphatase. Biochem Biophys Res Commun. 2011 Jun
24;410(1):87-90.
Schiffer E., Liabeuf S., Lacroix C., Temmar M.,
Renard C., Monsarrat B., Choukroun G., Lemke H.D., Vanholder R., Mischak
H., Massy Z.A. (2011). on behalf of the European Uremic Toxin Work Group
(EUTox). Markers
of vascular disease in plasma from patients with chronic kidney
disease identified by proteomic analysis. J Hypertens. 2011
Apr;29(4):783-790.
Lemaître G., Stella A., Feteira J., Baldeschi
C., Vaigot P., Martin M.T., Monsarrat B., Waksman G. (2011). CD98hc
(SLC3A2) is a key regulator of keratinocyte adhesion. J Dermatol
Sci. 2011 Mar;61(3):169-79. Epub 2011 Jan 11.
García-Gómez
J.J., Babiano R., Lebaron S., Froment C., Monsarrat B., Henry Y., de la
Cruz J. (2011). Nop6,
a component of 90S pre-ribosomal particles, is required for 40S
ribosomal subunit biogenesis in Saccharomyces cerevisiae. RNA
Biol. 2011 Jan 1;8(1):112-24.
Roux A.L., Ray A., Pawlik A.,
Medjahed H., Etienne G., Rottman M., Catherinot E., Coppée J.Y., Chaoui K.,
Monsarrat B., Toubert A., Daffé M., Puzo G., Gaillard J.L., Brosch R.,
Dulphy N., Nigou J., Herrmann J.L. (2011). Overexpression
of proinflammatory TLR-2-signalling lipoproteins in hypervirulent
mycobacterial variants. Cell Microbiol. 2011 May;13(5):692-704.
2010
Mischak H., Kolch W., Aivaliotis M., Bouyssié D., Court M.,
Dihazi H., Dihazi G.H., Franke J., Garin J., Gonzalez de Peredo A.,
Iphöfer A., Jänsch L., Lacroix C., Makridakis M., Masselon C.,
Metzger J., Monsarrat B., Mrug M., Novak J., Pich A., Pitt A.,
Schanstra J.P., Siwy J., Suzuki H., Thongboonkerd V., Wang L.H.,
Zoidakis J., Zürbig P. and Vlahou A. (2010). Comprehensive human
urine standards for comparability and standardization in clinical
proteome analysis. Proteomics Clinical Applications. 4(4):464-478.
Caubet C., Lacroix C., Decramer S., Drube J., Ehrich J.H.H.,
Mischak H., Bascands J. L. and Schanstra J. P. Advances in urinary
proteome analysis and biomarker discovery: potential use in
paediatric renal disease. (2010). Review. Pediatric Nephrology.
25(1):27-35.
Mazars R., Gonzalez-de-Peredo A., Cayrol C., Lavigne A.C., Vogel JL,
Ortega N., Lacroix C., Gautier V., Huet G., Ray A., Monsarrat B., Kristie
T.M. and Girard J.P. (2010). The thap-zinc finger protein thap1 associates with
coactivator HCF-1 and O-GLcNAc transferase: A link between DYT6 and
DYT3 dystonias.. J Biol Chem. 2010 Mar 3.
Jang J., Stella A.,
Boudou F., Levillain F., Darthuy E., Vaubourgeix J., Wang C., Bardou F.,
Gilleron M., Puzo G., Burlet-Schiltz O., Monsarrat B., Brodin P., Gicquel
B. and Neyrolles O. (2010). Functional characterization of the Mycobacterium
tuberculosis serine/threonine kinase PknJ. Microbiology. 2010 Feb
25.
Bonnart C., Deraison C., Lacroix M., Uchida Y., Besson C.,
Robin A., Briot A., Gonthier M., Lamant L., Dubus P., Monsarrat B.
and Hovnanian A. (2010). Elastase 2 is expressed in human and mouse epidermis
and impairs skin barrier function in Netherton syndrome through
filaggrin and lipid misprocessing. J. Clin Invest. 2010 Mar
1;120(3):871-82.
Dalenc F., Doisneau-Sixou S.F., Allal B.C.,
Marsili S., Lauwers-Cances V., Chaoui K., Schiltz O., Monsarrat B.,
Filleron T., Renée N., Malissein E., Meunier E., Favre G. and Roché H.
(2010). Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast
cancer: a negative phase II and screening of potential therapeutic
markers by proteomic analysis.. Clin Cancer Res. 2010 Feb
15;16(4):1264-71.
Mouton-Barbosa E., Roux-Dalvai F., Bouyssié
D., Berger F., Schmidt E., Righetti P.G., Guerrier L., Boschetti E.,
Burlet-Schiltz O., Monsarrat B. and Gonzalez de Peredo A. (2010). In depth
exploration of cerebrospinal fluid by combining peptide ligand
library treatment and label free protein quantification. Mol Cell
Proteomics. 2010 Jan 21.
2009
Matondo M.,
Bousquet-Dubouch M.P., Gallay N., Uttenweiler-Joseph S., Recher C.,
Payrastre B., Manenti S., Monsarrat B. and Burlet-Schiltz O. (2009). Proteasome
inhibitor-induced apoptosis in acute myeloid leukemia: A correlation
with the proteasome status.. Leuk Res. 2009 Oct 5.
Lebaron S.,
Papin C., Capeyrou R., Chen Y.L., Froment C., Monsarrat B.,
Caizergues-Ferrer M., Grigoriev M. and Henry Y. (2009). The ATPase and helicase
activities of Prp43p are stimulated by the G-patch protein Pfa1p
during yeast ribosome biogenesis.. EMBO J. 2009 Dec
16;28(24):3808-19.
Britton S., Froment C., Frit P., Monsarrat B., Salles B.
and Calsou P. (2009). Cell nonhomologous end joining capacity controls SAF-A
phosphorylation by DNA-PK in response to DNA double-strand breaks
inducers. Cell Cycle. 2009 Nov 15;8(22):3717-22.
Strande V. Canelle L., Tastet C., Burlet-Schiltz O., Monsarrat
B. and Hondermarck H. (2009). The proteome of the human breast
cancer cell line MDA-MDB-231 : Analysis by LTQ-Orbitrap mass
spectrometry. Proteomics Clin Appl 1, 41-50.
Bousquet-Dubouch M.P., Baudelet M.P., Guérin F., Matondo M.,
Uttenweiler-Joseph S., Burlet-Schiltz O. and Monsarrat B.
(2009). Affinity purification strategy to capture human endogeneous
proteasome complexes diversity and to identify proteasome
interacting proteins. Mol Cell Proteomics 8:1150-64.
Burande
C.F., Heuzé M.L., Monsarrat B., Uttenweiler-Joseph S. and Lutz,
P. G. (2009). A label-free quantitative proteomic strategy to
identify E3 ubiquitin ligase substrates targeted to proteasome
degradation. Mol Cell Proteomics, 2009, Jul. 8(7). 1719-1727.
CCabos-Siguier B., Steunou A.L., Joseph G., Alazard R., Ducoux-Petit
M., Nieto L., Monsarrat B., Erard M. and Clottes E. (2009). Expression and
purification of human full-length N Oct-3, a transcription factor
involved in melanoma growth. Protein Expr Purif. 2009
Mar;64(1):39-46.
Bousquet-Dubouch M. P., Nguen S.,
Bouyssié D., Burlet-Schiltz O., French S.W., Monsarrat B. and
Gorce-Bardag, F. (2009). Chronic ethanol feeding affects Proteasome
Interacting Proteins. Proteomics, 9(13):3609-22.
Stanislas T., Bouyssié D., Rossignol M., Vesa S., Fromentin J., Morel
J., Pichereaux C., Monsarrat B. and Simon-Plas F. (2009). Quantitative
proteomics reveals a dynamic association of proteins to detergent
resistant membranes elicitor signaling in tabacco. Mol Cell
Proteomics 2009, sep;8(9)2186-98.
Gavalda S., Léger M., Van
der Rest B., Stella A., Bardou F, Montrozier H., Chalut C., Burlet
–Schiltz O., Marrakchi H., Daffé M. and Quémard A. (2009). The Pks
13/FadD32 crosstalk for the biosynthesis of mycolic acids in
Mycobacterium tubercolisis. J Biol Chem. Jul 17;284(29):19255-64.
2008
Decramer S., Gonzalez de Peredo A., Breuil B., Mischak H., Monsarrat B.,
Bascands J.L. and Schanstra J.P. (2008). Urine in clinical proteomics. Mol
Cell Proteomics, 2008 Jul 30.
Roux-Dalvai F., Gonzalez de Peredo A., Simo C., Guerrier L., Bouyssié D.,
Zanella A., Citterio A., Burlet-Schiltz O., Boschetti E., Righetti P.G. and Monsarrat B. (2008). Extensive analysis of the cytoplasmic proteome of
human erythrocytes using the peptide ligand library technology and
advanced mass spectrometry. Mol Cell Proteomics, 2008 Jul 9.
Raymond A.A., Gonzalez de Peredo A., Stella A., Ishida-Yamamoto A., Bouyssié D.,
Serre G., Monsarrat B. and Simon M. (2008). Lamellar bodies of human
epidermis: Proteomic characterization by high-throughput mass
spectrometry, possible involvement of CLIP-170 in their trafficking/secretion.
Mol Cell Proteomics, 2008 Jul 12.
Uttenweiler-Joseph S., Claverol S., Sylvius L., Bousquet-Dubouch
M.P., Burlet-Schiltz O. and Monsarrat B. (2008). Towards a full
characterization of the human 20S proteasome subunits and their
isoforms by a combination of proteomic approaches. Methods Mol. Biol.,
484, 111-130.
Bousquet-Dubouch M.P., Uttenweiler-Joseph S., Ducoux-Petit M.,
Matondo M., Monsarrat B. and Burlet-Schiltz O. (2008).
Purification and Proteomic Analysis of 20S Proteasomes from Human
Cells. Methods Mol Biol., 432:301-20.
Ducoux-Petit M., Uttenweiler-Joseph S., Brichory F.,
Bousquet-Dubouch M.P., Burlet-Schiltz O., Haeuw J.F. and Monsarrat
B. (2008). Scaled-down purification protocol to access proteomic
analysis of 20S proteasome from human tissue samples: comparison of
normal and tumor colorectal cells. J. Proteome Res., 7, 2852-2859.
Bouché J.P., Froment C., Dozier C., Esmenjaud-Mailhat C., Lemaire
M., Monsarrat B., Burlet-Schiltz O. and Ducommun B. (2008). NanoLC-MS/MS
analysis provide new insights into the phosphorylation pattern of
Cdc25B in vivo: full overlap with sites of phosphorylation by Chk1
and Cdk1/cycB kinases in vitro.J. Proteome Res., 7, 1264-1273.
Bousquet-Dubouch M.P., Uttenweiler-Joseph S., Ducoux-Petit M.,
Matondo M., Monsarrat B. and Burlet-Schiltz O. (2008). Purification
and proteomic analysis of 20S proteasomes from human cells. Methods
Mol. Biol., 432, 301-320.
2007
Nieto L., Joseph G., Stella A., Henri P., Burlet-Schiltz
O., Monsarrat B., Clottes E. and Erard M. (2007). Differential
effects of phosphorylation on DNA binding properties of N-OCT-3 are
dictated by protein/DNA complex structures. J. Mol. Biol., 370,
687-700.
Bouyssié D., Gonzalez de Peredo A., Mouton E., Albigot R.,
Roussel L., Ortega N., Cayrol C., Burlet-Schiltz O., Girard J.P. and
Monsarrat B. (2007). MFPaQ, a new software to parse, validate, and
quantify proteomic data generated by ICAT and SILAC mass
spectrometric analyses: application to the proteomic study of
membrane proteins from primary human endothelial cells.Mol. Cell.
Proteomics, 6, 1621-1637.
2006
Cussac D., Pichereaux C., Colomba A., Capilla F., Pont F., Gaits-Iacovoni
F., Lamant L., Espinos E., Burlet-Schiltz O., Monsarrat B., DelsolG.
and Payrastre B. (2006). Proteomic analysis of anaplastic lymphoma
cell lines: Identification of potential tumor markers.
Proteomics,
6, 3210-3222.
Chapiro J., Claverol S., Piette F.,
Ma W, Stroobant V., Guillaume B., Gairin J.E., Morel S., Burlet-Schiltz
O., Monsarrat B., Boon T. and Van den Eynde B.J. (2006). Destructive
cleavage of antigenic peptides either by the immunoproteasome or by
the standard proteasome results in differential antigen presentation.
J Immunol., 176(2):1053-61.
Années antérieures
Burlet-Schiltz O., Claverol S., Gairin
J.E. and Monsarrat B. (2005). The use of mass spectrometry to
identify antigens from proteasome processing. Methods Enzymol.,
405:264-300. Review.
Froment C., Uttenweiler-Joseph S., Bousquet-Dubouch M. P.,
Matondo M., Borges J.P., Esmenjaud C., Lacroix C., Monsarrat B. and
Burlet-Schiltz O. (2005). A quantitative proteomic approach using
2-D gel electrophoresis and Isotope-Coded Affinity Tag for studying
Human 20S proteasome heterogeneity. Proteomics, 5(9):2351-63.
Chapatte L., Servis C., Valmori D., Burlet-Schiltz O., Dayer J.,
Monsarrat B., Romero P. and Levy F. (2004). Final antigenic Melan-A
peptides produced directly by the proteasomes are preferentially
selected for presentation by HLA-A*0201 in melanoma cells, J Immunol,
15, 173, 6033-40.
Claverol S., Burlet-Schiltz O., Gairin J.E. and Monsarrat B.
(2003). Characterization of proteins variants and Post-Translational
Modifications: ESI-MSn Analyses of Intact Proteins Eluted from
Polyacrylamide Gels, Mol. Cell. Proteomics, 2.8, 483-493.
E. S. Schultz, J. Chapiro, C. Lurquin, S. Claverol, O. Burlet
Schiltz, G. Warnier, V. Russo, S. Morel, F. Lévy, T. Boon, B. Van
den Eynde, P. van der Bruggen (2002). The production of an New
Mage-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40
Requires the Immunoproteasome, J. Exp. Med., 195, 4, 391-399.
L. Thion, E. Laurine, M. Erard, O. Burlet-Schiltz, B. Monsarrat,
and I. Saves (2002) The two step clivage of PI-Tful intein
endonuclease demonstrated by matrix-assisted Laser Desorption
Ionization Time-of-Flight mass spectrometry, J. Biol. Chem., 277,
45442-454450.
Claverol S., Burlet-Schiltz O. Neuhauser E., Gairin J.E, and
Monsarrat B. (2002) Mapping and Structural Dissection of Human 20S
Proteasome using Proteomics Approaches. Molecular and Cellular,
Proteomics, 1.8, 567-578.
Ludwiczak P., Th. Brando, B. Monsarrat, and G. Puzo. (2001)
Structural Characterization of Mycobacterium Tuberculosis
Lipoarabinomannans by the Combination of Capillary Electrophoresis
and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass
Spectrometry, Anal. Chem., 73, 2323-2330. |
